Drugs / Read vine leaf extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00292435 | Mar → Oct 2006 | venous insufficiency | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Read vine leaf extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00292435 ↗ |
| Known as | AS 195 | “Read vine leaf extract (AS 195)” NCT00292435 ↗ |
| Route | Oral | “360 mg/Day Orally” NCT00292435 ↗ |